AstraZeneca, Lilly, Merck contribute $120M to support manufacturing talent in Virginianews2025-11-03T13:19:48+00:00November 3rd, 2025|Endpoints News|
National Resilience secures $825M in funding; Regeneron details US manufacturing plansnews2025-10-30T15:34:59+00:00October 30th, 2025|Endpoints News|
Lilly budgets $1.2B for GLP-1 pill factory in Puerto Rico news2025-10-29T17:38:18+00:00October 29th, 2025|Endpoints News|
WuXi AppTec to shutter Texas-based clinical research business news2025-10-29T10:31:41+00:00October 29th, 2025|Endpoints News|
WuXi AppTec to divest clinical services to focus on manufacturing businessnews2025-10-27T13:42:32+00:00October 27th, 2025|Endpoints News|
FDA uncovers unauthorized Indian API warehouse with lizards, catsnews2025-10-24T18:15:00+00:00October 24th, 2025|Endpoints News|
Merck KGaA to end API work at Irish plant after ‘strategic portfolio review’news2025-10-23T16:24:04+00:00October 23rd, 2025|Endpoints News|
Lonza expects more CDMO contracts; Galderma’s $650M US commitmentnews2025-10-23T15:55:08+00:00October 23rd, 2025|Endpoints News|
Drugmakers push to break ground after Trump’s 100% tariff threatnews2025-10-23T13:27:43+00:00October 23rd, 2025|Endpoints News|
Thermo Fisher, Danaher stand to gain from drugmakers’ onshoring effortsnews2025-10-22T17:11:30+00:00October 22nd, 2025|Endpoints News|
